NADINOLA SKIN DISCOLORATION FADE CREAM-S.C.F 2 %
HYDROQUINONE : 2 % · DIN 02040670 · NADINOLA INC.
Health Canada status: CANCELLED POST MARKET
What is NADINOLA SKIN DISCOLORATION FADE CREAM-S.C.F?
NADINOLA SKIN DISCOLORATION FADE CREAM-S.C.F 2 % contains HYDROQUINONE : 2 %. It is listed in the Health Canada Drug Product Database under DIN 02040670, held by NADINOLA INC., supplied as CREAM for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 27-Jun-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02040670 |
|---|---|
| Brand name | NADINOLA SKIN DISCOLORATION FADE CREAM-S.C.F |
| Generic / active ingredient | HYDROQUINONE : 2 % |
| Manufacturer | NADINOLA INC. |
| Strength | 2 % |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D11AX11 HYDROQUINONE |
| AHFS class | 84:50.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 27-Jun-2001 |
| Original market date | 1994-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D11AX11 HYDROQUINONE. 1 of 67 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ERFA HYDROQUINONE | 4 % | GEL | SEARCHLIGHT PHARMA INC | MARKETED | DIN 02491702 |
| ACTIVE 4 | 4 % | CREAM | VIVIER CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02248851 |
| AFRICAN GOLD SKIN DISCOLORATION FADE CRM 2% | 2 % | CREAM | J. STRICKLAND & CO. | CANCELLED POST MARKET | DIN 02029227 |
| AMBI EXTRA SKIN DISCOLORATION FADE CREAM | 2 % | CREAM | KIWI BRANDS INC. | CANCELLED POST MARKET | DIN 02083337 |
| BANISHING CREAM | 2 % | CREAM | THE AVON COMPANY CANADA LIMITED | CANCELLED POST MARKET | DIN 00602736 |
| BLACK OPAL ADVANCE DUAL COMPLEX FADE GEL | 2 % | GEL | BIOCOSMETIC RESEARCH LABS DIVISION OF MANA PRODUCTS INC. | CANCELLED (UNRETURNED ANNUAL) | DIN 02240657 |
| BLACK OPAL ADVANCED DUAL PHASE FADE CREME | 2 % | CREAM | BIOCOSMETIC RESEARCH LABS DIVISION OF MANA PRODUCTS INC. | CANCELLED (UNRETURNED ANNUAL) | DIN 02240656 |
| CLAIRISSIME CLEAR COMPLEXION LOTION | 2 % | LOTION | AYOTAI CANADA INC. | CANCELLED POST MARKET | DIN 02251590 |
| CLEAR ESSENCE MEDICATED FADE CREAM | 2.5 % | CREAM | BLUEFIELD ASSOCIATES, INC. | CANCELLED (UNRETURNED ANNUAL) | DIN 02239114 |
| CLEAR-N-SMOOTH | 2 % | CREAM | HAWKNAD MANUFACTURING INDUSTRIES, INC. | CANCELLED (UNRETURNED ANNUAL) | DIN 02237828 |
Who else supplies HYDROQUINONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. HYDROQUINONE appears in 23 registered pack listings across 4 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.